Article
Multiple Myeloma: Combination Therapy of BET Proteolysis Targeting Chimeric Molecule with…
medRxiv · 2020 · Lim, S. L.; Koeffler, P.; Xu, L.; Han, B. C.; Shyamsunder, P.; Chng, W. J.
Key facts
| Title | Multiple Myeloma: Combination Therapy of BET Proteolysis Targeting Chimeric Molecule with CDK9 Inhibitor |
|---|---|
| First author | Lim, S. L.; Koeffler, P.; Xu, L.; Han, B. C.; Shyamsunder, P.; Chng, W. J. |
| Journal | medRxiv |
| Published | Apr 8, 2020 |
| DOI | 10.1101/2020.04.08.031583 |
| Devices mentioned | K103302 |
| Product codes mentioned | NDS, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1